71 related articles for article (PubMed ID: 38524630)
1. Virtual Care for Patients with Advanced Well Differentiated Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).
Phillips WJ; Pradier M; Goodwin R; Vickers M; Asmis T
Curr Oncol; 2024 Feb; 31(2):952-961. PubMed ID: 38392065
[TBL] [Abstract][Full Text] [Related]
2. PCDHGC3 hypermethylation as a potential biomarker of intestinal neuroendocrine carcinomas.
Cubiella T; Celada L; San-Juan-Guardado J; Rodríguez-Aguilar R; Suárez-Priede Á; Poch M; Dominguez F; Fernández-Vega I; Montero-Pavón P; Fraga MF; Nakatani Y; Takata S; Yachida S; Valdés N; Chiara MD
J Pathol; 2024 May; ():. PubMed ID: 38795318
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia and Neuroendocrine Neoplasms.
Clement D; Brown S; Leerdam MV; Tesselaar M; Ramage J; Srirajaskanthan R
Curr Oncol Rep; 2024 Feb; 26(2):121-128. PubMed ID: 38270848
[TBL] [Abstract][Full Text] [Related]
4. CXCR4: From Signaling to Clinical Applications in Neuroendocrine Neoplasms.
Sanchis-Pascual D; Del Olmo-García MI; Prado-Wohlwend S; Zac-Romero C; Segura Huerta Á; Hernández-Gil J; Martí-Bonmatí L; Merino-Torres JF
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791878
[TBL] [Abstract][Full Text] [Related]
5. Advances in the diagnosis and treatment of gastric neuroendocrine neoplasms.
Tan H
Transl Gastroenterol Hepatol; 2016; 1():87. PubMed ID: 28138652
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.
Fazio N; Milione M
Cancer Treat Rev; 2016 Nov; 50():61-67. PubMed ID: 27636009
[TBL] [Abstract][Full Text] [Related]
7. Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.
Holmager P; Langer SW; Kjaer A; Ringholm L; Garbyal RS; Pommergaard HC; Hansen CP; Federspiel B; Andreassen M; Knigge U
Curr Treat Options Oncol; 2022 Jun; 23(6):806-817. PubMed ID: 35362798
[TBL] [Abstract][Full Text] [Related]
8. Expression and clinical value of CXCR4 in high grade gastroenteropancreatic neuroendocrine neoplasms.
Pang C; Li Y; Shi M; Fan Z; Gao X; Meng Y; Liu S; Gao C; Su P; Wang X; Zhan H
Front Endocrinol (Lausanne); 2024; 15():1281622. PubMed ID: 38524630
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
11. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
[TBL] [Abstract][Full Text] [Related]
12. A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations.
Elvebakken H; Perren A; Scoazec JY; Tang LH; Federspiel B; Klimstra DS; Vestermark LW; Ali AS; Zlobec I; Myklebust TÅ; Hjortland GO; Langer SW; Gronbaek H; Knigge U; Tiensuu Janson E; Sorbye H
Neuroendocrinology; 2021; 111(9):883-894. PubMed ID: 33002892
[TBL] [Abstract][Full Text] [Related]
13. APOBEC3B High Expression in Gastroenteropancreatic Neuroendocrine Neoplasms and Association With Lymph Metastasis.
Feng C; Zheng Q; Yang Y; Xu M; Lian Y; Huang J; Jiang Y
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):599-605. PubMed ID: 30095460
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53 and Rb reveal subtypes of gastric neuroendocrine carcinoma with distinct prognosis.
Xing J; Chen J; You T; Sun Z; Lu T; Cheng Y; Wu H; Bai C
J Neuroendocrinol; 2023 Apr; 35(4):e13257. PubMed ID: 36964649
[TBL] [Abstract][Full Text] [Related]
15. Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor Prognosis.
Bremer SCB; Bittner G; Elakad O; Dinter H; Gaedcke J; König AO; Amanzada A; Ellenrieder V; Freiherr von Hammerstein-Equord A; Ströbel P; Bohnenberger H
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740494
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
